Values are displayed in Millions | Trend | 12/31/2015 | 12/31/2016 | 12/31/2017 | 12/31/2018 |
---|---|---|---|---|---|
Net Revenues | 23,633 | 15,887 | 20,620 | 23,995 | |
Cost of Goods Sold | 19,278 | 13,520 | 16,799 | 19,403 | |
Depreciation And Amortization | 1,835 | 1,503 | 1,556 | 1,606 | |
Gross Income | 2,520 | 864 | 2,265 | 2,986 | |
General Expenses | 200 | 228 | 256 | 254 | |
Other Operating Expenses | 484 | 166 | 0 | 0 | |
Research And Development | 0 | N/A | N/A | N/A | |
Total Operating Expenses | 21,797 | 15,417 | 18,611 | 21,263 | |
Operating Income | 1,836 | 470 | 2,009 | 2,732 | |
Extraordinary Credit | 0 | 0 | N/A | N/A | |
Extraordinary Charge | -2,001 | -7,302 | -647 | -265 | |
Interest Expense On Debt | 463 | 698 | 705 | 598 | |
Other Expenses | -324 | -154 | -87 | -99 | |
Pre-Tax Income | -936 | -7,625 | 682 | 1,814 | |
Income Taxes | -274 | -1,858 | -1,131 | -157 | |
Minority Interest | -4 | -6 | -5 | -1 | |
Net Income Before Preferreds and Extraordinary Items | -671 | -5,763 | -463 | 1,656 | |
Preferred Dividend | 0 | 0 | 0 | 0 | |
Discontinued Operations | -5 | -2 | -19 | 0 | |
Income Available for Common | -666 | -5,761 | -444 | 1,656 | |
Shares To Calculate EPS | 853 | 861 | 870 | 875 | |
Shares To Calculate EPS Diluted | 853 | 861 | 870 | 877 | |
EPS | -0.79 | -6.69 | -0.53 | 1.89 | |
EPS Diluted | -0.79 | -6.69 | -0.53 | 1.89 | |
Filing Type | Filing Category | Filing Date |
---|---|---|
8-K/A | Company Events | 05/19/2022 |
8-K | Company Events | 05/19/2022 |
DEFA14A | Proxy Statement | 05/09/2022 |
8-K | Company Events | 05/02/2022 |
8-K | Company Events | 04/28/2022 |
10-Q | Quarterly Financials | 04/22/2022 |
8-K | Company Events | 04/19/2022 |
4 | Insider Buy/Sell | 04/19/2022 |
4 | Insider Buy/Sell | 04/18/2022 |
4 | Insider Buy/Sell | 04/13/2022 |
4 | Insider Buy/Sell | 04/13/2022 |
4 | Insider Buy/Sell | 04/13/2022 |
4 | Insider Buy/Sell | 04/12/2022 |
4 | Insider Buy/Sell | 04/12/2022 |
4 | Insider Buy/Sell | 04/12/2022 |
DEFA14A | Proxy Statement | 04/05/2022 |
DEF 14A | Proxy Statement | 04/05/2022 |
4 | Insider Buy/Sell | 04/04/2022 |
4 | Insider Buy/Sell | 04/04/2022 |
4 | Insider Buy/Sell | 04/04/2022 |